These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 10992179)
21. Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits. Pedersen NG; Pedersen SH; Dalsgaard T; Lund CO; Nilas L; Ottesen B Maturitas; 2004 Dec; 49(4):304-14. PubMed ID: 15531126 [TBL] [Abstract][Full Text] [Related]
22. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene. Lambrinoudaki IV; Christodoulakos GE; Economou EV; Vlachou SA; Panoulis CP; Alexandrou AP; Kouskouni EE; Creatsas GC Maturitas; 2008 Jan; 59(1):62-71. PubMed ID: 18164562 [TBL] [Abstract][Full Text] [Related]
23. The effects of sex steroid replacement therapy on an expanded panel of IGF-related peptides. Renehan AG; Frystyk J; Howell A; O'dwyer ST; Shalet SM; Flyvbjerg A Growth Horm IGF Res; 2007 Jun; 17(3):210-9. PubMed ID: 17360217 [TBL] [Abstract][Full Text] [Related]
24. Relationship between a wide range of alcohol consumptions, components of the insulin-like growth factor system and adiponectin. Dal Maso L; La Vecchia C; Augustin LS; Mantzoros CS; Kendall CW; Franceschi S Eur J Clin Nutr; 2007 Feb; 61(2):221-5. PubMed ID: 16969380 [TBL] [Abstract][Full Text] [Related]
25. Progestins initiate adverse events of menopausal estrogen therapy. Thomas T; Rhodin J; Clark L; Garces A Climacteric; 2003 Dec; 6(4):293-301. PubMed ID: 15011717 [TBL] [Abstract][Full Text] [Related]
26. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes. Hedman CA; Frystyk J; Fridell K; Jönsson A; Flyvbjerg A; Lindström T; Arnqvist HJ Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412 [TBL] [Abstract][Full Text] [Related]
27. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate. Odmark IS; Jonsson B; Bäckström T Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178 [TBL] [Abstract][Full Text] [Related]
28. The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment. Zimmermann-Belsing T; Juul A; Juul Holst J; Feldt-Rasmussen U Growth Horm IGF Res; 2004 Jun; 14(3):235-44. PubMed ID: 15125885 [TBL] [Abstract][Full Text] [Related]
29. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy. Milliken LA; Going SB; Houtkooper LB; Flint-Wagner HG; Figueroa A; Metcalfe LL; Blew RM; Sharp SC; Lohman TG Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871 [TBL] [Abstract][Full Text] [Related]
30. The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women. Demir B; Ozturkoglu E; Solaroglu A; Baskan B; Kandemir O; Karabulut E; Haberal A Gynecol Endocrinol; 2008 Jun; 24(6):347-53. PubMed ID: 18584415 [TBL] [Abstract][Full Text] [Related]
31. [Effects of L-arginine on the expression of insulin-like growth factors and insulin-like growth factor binding protein 3 in rats with intrauterine growth retardation]. Lu Y; Liu XM; Li SQ Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):319-22. PubMed ID: 16923367 [TBL] [Abstract][Full Text] [Related]
32. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT. Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837 [TBL] [Abstract][Full Text] [Related]
33. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates. Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235 [TBL] [Abstract][Full Text] [Related]
34. Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial. de Kraker AT; Kenemans P; Smolders RG; Kroeks MV; van der Mooren MJ Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):139-44. PubMed ID: 19095343 [TBL] [Abstract][Full Text] [Related]
35. Changes in profiles of circulating insulin-like growth factor components during hormone replacement therapy according to the responsiveness to therapy in postmenopausal women. Kim JG; Lee JY Am J Obstet Gynecol; 2001 May; 184(6):1139-44. PubMed ID: 11349179 [TBL] [Abstract][Full Text] [Related]
36. A comparison of the central effects of different progestins used in hormone replacement therapy. Cagnacci A; Arangino S; Baldassari F; Alessandrini C; Landi S; Volpe A Maturitas; 2004 Aug; 48(4):456-62. PubMed ID: 15283939 [TBL] [Abstract][Full Text] [Related]
37. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels. Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257 [TBL] [Abstract][Full Text] [Related]
38. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202 [TBL] [Abstract][Full Text] [Related]
39. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis]. Liang LJ; Luo SM; Hu WJ Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):697-701. PubMed ID: 16008955 [TBL] [Abstract][Full Text] [Related]
40. Physiologic and pharmacologic effects of estrogen and progestins on bone. DeCherney A J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]